StockData
Abbott Laboratories logo

Abbott Laboratories (ABT) operating KPIs

ABTNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 28, 2026Score 14/3036% above fair value
$106.20+1.63 (+1.56%)

Close on Oct 30, 2026Market cap $183.77BP/E 34.1Yield 2.26%

Abbott Laboratories buildings — Gross ($M) ($M)

Form 10-K / 10-Q Supplemental Balance Sheet Footnote

Latest, FY2025
4,543
Period ended Dec 31, 2025
Change on a year earlier
+8.0%
4,207 in FY2024
History
13 years
Since FY2013
Sources
12
Documents cited below

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedBuildings — Gross ($M) ($M)Year on yearSource
FY2025Dec 31, 20254,543+8.0%SEC Filing (0001628280-26-010185) ↗
FY2024Dec 31, 20244,207+1.1%SEC Filing (0001628280-26-010185) ↗
FY2023Dec 31, 20234,161+2.7%SEC Filing (0001628280-25-007110) ↗
FY2022Dec 31, 20224,053+1.1%SEC Filing (0001628280-24-005348) ↗
FY2021Dec 31, 20214,007-0.2%SEC Filing (0001628280-23-004026) ↗
FY2020Dec 31, 20204,014+8.4%SEC Filing (0001104659-22-025141) ↗
FY2019Dec 31, 20193,702+4.1%SEC Filing (0001104659-21-025751) ↗
FY2018Dec 31, 20183,555-1.6%SEC Filing (0001104659-20-023904) ↗
FY2017Dec 31, 20173,613+38.9%SEC Filing (0001047469-19-000624) ↗
FY2016Dec 31, 20162,602-6.0%SEC Filing (0001047469-18-000856) ↗
FY2015Dec 31, 20152,769-6.7%SEC Filing (0001047469-17-000744) ↗
FY2014Dec 31, 20142,968-0.9%SEC Filing (0001047469-16-010246) ↗
FY2013Dec 31, 20132,994–SEC Filing (0001047469-15-001377) ↗

Cite this data

StockData. (2026). Abbott Laboratories Buildings — Gross ($M) ($M), annual FY2013–FY2025 [Data set]. Compiled from Abbott Laboratories SEC filings and investor materials. https://stockdatahq.com/stocks/abt/kpis/xbrl-ppe-bldg

See every metric in the Abbott Laboratories KPI table. Data updated Oct 29, 2026.